CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-31 | Bristol James Arthur Director | Grant or award · Stock Option (Right to buy) | +8,320 | 8,320 | ||
| 2026-08-31 | Bristol James Arthur Director | Grant or award · Stock Option (Right to buy) | +5,083 | 5,083 | ||
| 2026-08-31 | Cicala Peter Director | Grant or award · Stock Option (Right to buy) | +5,943 | 5,943 | ||
| 2026-08-31 | Cicala Peter Director | Grant or award · Stock Option (Right to buy) | +5,083 | 5,083 | ||
| 2026-08-31 | Polinsky David Director | Grant or award · Stock Option (Right to buy) | +5,083 | 5,083 | ||
| 2026-08-31 | Wexler William A. Director | Grant or award · Stock Option (Right to buy) | +5,943 | 5,943 | ||
| 2026-08-31 | Ratner Elena Director | Grant or award · Stock Option (Right to buy) | +5,944 | 5,944 | ||
| 2026-08-31 | Luther Sanjeev President and CEO | Grant or award · Stock Option (right to buy) | +118,848 | 118,848 | ||
| 2026-02-10 | Cherington Charles 10% owner | Purchase | +4,000,000 | $0.50 | $2.0M | 6,779,440 |
| 2026-02-10 | Cherington Charles 10% owner | Purchase · Warrants to Purchase Common Stock | +4,000,000 | 4,000,000 | ||
| 2025-06-21 | Gurrola Sandra M Sr. VP of Finance | Option exercise | +30 | 110 | ||
| 2025-06-21 | Gurrola Sandra M Sr. VP of Finance | Option exercise · Restricted Stock Units | +30 | 0 | ||
| 2025-06-09 | Cherington Charles 10% owner | Purchase | +21,241,163 | $0.10 | $2.2M | 41,659,743 |
| 2025-04-02 | Cherington Charles 10% owner | Purchase | +3,768,397 | $0.10 | $394K | 20,401,602 |
| 2025-02-07 | Wexler William A. Director | Grant or award · Stock Option (right to buy) | +124,533 | 124,533 | ||
| 2025-02-07 | Gurrola Sandra M Sr. VP of Finance | Grant or award · Stock Option (Right to buy) | +150,000 | 150,000 | ||
| 2025-02-07 | Bristol James Arthur Director | Grant or award · Stock Option (Right to buy) | +72,074 | 72,074 | ||
| 2025-02-07 | Cicala Peter Director | Grant or award · Stock Option (Right to buy) | +51,485 | 51,485 | ||
| 2025-02-07 | Luther Sanjeev President & CEO | Grant or award · Stock Option (right to buy) | +1,123,350 | 1,123,350 | ||
| 2025-01-13 | Ratner Elena Director | Grant or award · Stock Option (Right to buy) | +140,078 | 140,078 |
Page 1 of 33 · 657 trades